Editorial
Accepted on 13 Feb 2026
Editorial: COVID and Psychotropics 2024: Lessons Learnt and Future Directions for Research
in Psychopharmacology
Frontiers in Psychiatry
Type at least 3 characters
616 articles
articles
Case Report
Published on 11 Feb 2026
Case Report: Atypical neuroleptic malignant syndrome induced by paliperidone palmitate—diagnostic challenges and clinical considerations
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1718815
- 420 views
Hypothesis and Theory
Published on 09 Feb 2026
Sex-informed estrogen receptor modulation in schizophrenia: a male-focused ERβ/GPER1 framework for cognitive and negative symptoms
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1714569
- 500 views
Brief Research Report
Published on 04 Feb 2026
Agmatine augmentation in treatment-resistant obsessive-compulsive disorder: a prospective open-label case series
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1745041
- 858 views
Original Research
Published on 30 Jan 2026
Antipsychotic prescribing patterns in a state psychiatric hospital with predominantly forensic admissions
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1736853
- 741 views
Original Research
Published on 30 Jan 2026
Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1736922
- 1,033 views
Original Research
Accepted on 28 Jan 2026
Antipsychotics Lower Peripheral Markers of Inflammation in Drug-naïve Early Psychosis: A Pilot Study
in Psychopharmacology
Frontiers in Psychiatry
- 234 views
Review
Published on 28 Jan 2026
High hopes? Precision psychedelic addiction medicine
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1681795
- 1,412 views
Case Report
Published on 28 Jan 2026
Promethazine-induced neuroleptic malignant syndrome under general anesthesia: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1700644
- 500 views
Case Report
Published on 23 Jan 2026
Case Report: Scurvy—a modifiable cause of psychiatric refractoriness and lithium pharmacokinetic abnormalities in autism
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1741734
- 695 views
Original Research
Published on 23 Jan 2026
Two-injection start regimen of long-acting aripiprazole for bipolar disorder: tips and tricks for better efficacy and tolerability
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1627052
- 705 views
Original Research
Published on 23 Jan 2026
Clinical predictors of short-term treatment response in stupor: a retrospective study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1714338
- 655 views
Case Report
Accepted on 19 Jan 2026
Reversible Aripiprazole-Related Tardive Dyskinesia in Saudi Arabia: A Case Series and Literature Review
in Psychopharmacology
Frontiers in Psychiatry
- 197 views
Mini Review
Accepted on 12 Jan 2026
Ketamine as an NMDA-Modulating Therapy in Bipolar Disorder: Rationale and Evidence
in Psychopharmacology
Frontiers in Psychiatry
- 387 views
Opinion
Published on 12 Jan 2026
Five years after the pandemic: rethinking the pharmacological management of mental disorders
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1750073
- 960 views
Original Research
Published on 12 Jan 2026
The effect of antidepressant medication use on HbA1c levels in type 2 diabetes
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1693817
- 939 views
Original Research
Published on 05 Jan 2026
Reduced risk of severe COVID-19 with lithium use: a large-scale comparison with valproate users and other COVID-19 patients
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1702189
- 849 views
Case Report
Published on 17 Dec 2025
Case Report: A possible association between significant dissociations after esketamine treatment and histrionic personality disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1666781
- 1,407 views
Correction
Published on 10 Dec 2025
Correction: OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1754488
- 569 views
Original Research
Published on 09 Dec 2025
How do psychedelics impact people with a history of non-affective psychosis? A qualitative study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1716545
- 2,685 views
Case Report
Published on 04 Dec 2025
Ketamine in post-stroke depression: a report of 2 cases
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1680687
- 1,457 views
Case Report
Published on 25 Nov 2025
Case Report: Development of persistent genital arousal disorder due to a possible combination of medications
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1709728
- 1,883 views
Original Research
Published on 21 Nov 2025
OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1718106
- 1,171 views
Editorial
Published on 18 Nov 2025
Editorial: Enhancing therapeutic strategies: a focus on pharmacovigilance in new wave antidepressants and antipsychotics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1706980
- 1,859 views